Marc E. Uknis, MD, FACS, MBA

Delaware Crossing Investor Group DCIG is a network of former and current executives and entrepreneurs who provide counsel and capital to early-stage companies. Over the past 13 years, members have backed entrepreneurs and their companies with investment capital and key domain expertise across a wide array of industries. Most of DCIG’s investments are in the Mid-Atlantic Region and often in conjunction with other angel groups and early stage venture capitalists. DCIG meets monthly alternating between Doylestown, PA and Princeton, NJ.

At UMass Chan Medical School, its not just what we do that makes us world-renowned. Its how we do it—together. We train the next generation of doctors, scientists and advanced practice nurses, lead groundbreaking research and clinical trials, and work to make our communities healthier. Our drive to collaborate and share knowledge creates important discoveries and inspires caregivers who put you first, offering hope for families struggling with ALS, cancer, diabetes and hundreds of rare diseases. Massachusetts’ first and only public academic health sciences center is made up of three graduate schools—advancing medicine, biomedical sciences and nursing, as well as two business divisions, ForHealth Consulting at UMass Chan Medical School and MassBiologics. Perennially ranked among the top medical schools for primary care education by U.S. News & World Report, UMass Chan is also an international leader in biomedical research and has been named a Top Place to Work. ForHealth Consulting at UMass Chan Medical School provides a wide range of care management and consulting services to government agencies, nonprofits and health care organizations, improving health care for people in need while maximizing revenue for clients and performing cutting edge research that impacts health policy. MassBiologics, the only nonprofit, FDA-licensed manufacturer of vaccines and biologics in the United States, improves public health through applied research, development and production of biologic products, including vaccines, plasma derivatives and monoclonal antibodies. At UMass Chan, our unique culture of inclusiveness and collaboration attracts some of the brightest students and faculty from around the world. Follow us to see how UMass Chan is advancing together.